Inflammatory processes and elevated osteoclast activity chaperon atrophic non-union establishment in a murine model

[1]  B. Arumugam,et al.  Characterization of Runx2 phosphorylation sites required for TGF‐β1‐mediated stimulation of matrix metalloproteinase‐13 expression in osteoblastic cells , 2018, Journal of cellular physiology.

[2]  Yuan Gao,et al.  miR-628-3p regulates osteoblast differentiation by targeting RUNX2: Possible role in atrophic non-union , 2016, International journal of molecular medicine.

[3]  S. Weiss,et al.  Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease. , 2016, The Journal of clinical investigation.

[4]  A. Daigeler,et al.  Human scaphoid non‐unions exhibit increased osteoclast activity compared to adjacent cancellous bone , 2015, Journal of cellular and molecular medicine.

[5]  G. Zhai,et al.  Overexpression of MMP13 in human osteoarthritic cartilage is associated with the SMAD-independent TGF-β signalling pathway , 2015, Arthritis Research & Therapy.

[6]  P. Gregersen,et al.  A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[7]  S. Dong,et al.  DC‐STAMP, the Key Fusion‐Mediating Molecule in Osteoclastogenesis , 2014, Journal of cellular physiology.

[8]  Hamish Simpson,et al.  Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. , 2014, Injury.

[9]  J. Zwerina,et al.  Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation , 2014, BMC Musculoskeletal Disorders.

[10]  Changqing Zhang,et al.  Screening of differentially expressed genes associated with non-union skeletal fractures and analysis with a DNA microarray , 2014, Experimental and therapeutic medicine.

[11]  A. H. Zulkifly,et al.  Factors associated with the outcome of open tibial fractures. , 2013, The Malaysian journal of medical sciences : MJMS.

[12]  D. Magne,et al.  Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells. , 2013, Biochemical and biophysical research communications.

[13]  H. Takayanagi.  New developments in osteoimmunology , 2012, Nature Reviews Rheumatology.

[14]  M. Waltham,et al.  An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer , 2012, PloS one.

[15]  M. Menger,et al.  Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins. , 2012, The Journal of bone and joint surgery. American volume.

[16]  G. Schmidmaier,et al.  Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model. , 2011, European cells & materials.

[17]  L. Glimcher,et al.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. , 2011, The Journal of clinical investigation.

[18]  R. West,et al.  Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway , 2011, BMC musculoskeletal disorders.

[19]  M. Longaker,et al.  Locally Applied Vascular Endothelial Growth Factor A Increases the Osteogenic Healing Capacity of Human Adipose‐Derived Stem Cells by Promoting Osteogenic and Endothelial Differentiation , 2011, Stem cells.

[20]  V. Bühren,et al.  Extracorporeal Shock Wave Therapy: Current Evidence , 2010, Journal of orthopaedic trauma.

[21]  Georg N Duda,et al.  Insight into the molecular pathophysiology of delayed bone healing in a sheep model. , 2010, Tissue engineering. Part A.

[22]  H. Takayanagi.  Osteoimmunology and the effects of the immune system on bone , 2009, Nature Reviews Rheumatology.

[23]  T. Wirth,et al.  TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. , 2009, Bone.

[24]  A. Freemont,et al.  Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  Yi Tang,et al.  TGF-β1-induced Migration of Bone Mesenchymal Stem Cells Couples Bone Resorption and Formation , 2009, Nature Medicine.

[26]  D. Stewart,et al.  Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  M. Menger,et al.  Development of a reliable non-union model in mice. , 2008, The Journal of surgical research.

[28]  G. Schett,et al.  Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. , 2008, Trends in molecular medicine.

[29]  A. Simpson,et al.  Inhibition of fracture healing. , 2007, The Journal of bone and joint surgery. British volume.

[30]  M. Dominkus,et al.  Metatarsal reconstruction with use of free vascularized osteomyocutaneous fibular grafts following resection of malignant tumors of the midfoot. A series of six cases. , 2007, The Journal of bone and joint surgery. American volume.

[31]  L. Tagliabue,et al.  Risk factors contributing to fracture non-unions. , 2007, Injury.

[32]  D. Graves,et al.  Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Kozo Nakamura,et al.  Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. , 2007, Biochemical and biophysical research communications.

[34]  Diane Hu,et al.  Ischemia leads to delayed union during fracture healing: A mouse model , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  N. Pavlos,et al.  Bone allograft non-union is related to excessive osteoclastic bone resorption: a sheep model study. , 2006, Histology and histopathology.

[36]  A. Reddi,et al.  Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[37]  I. Hvid,et al.  Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. , 2005, The Journal of bone and joint surgery. British volume.

[38]  W. Richter,et al.  TGF-β1 as a marker of delayed fracture healing , 2005 .

[39]  E. Schwarz,et al.  RANK Signaling Is Not Required for TNFα‐Mediated Increase in CD11bhi Osteoclast Precursors but Is Essential for Mature Osteoclast Formation in TNFα‐Mediated Inflammatory Arthritis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Jill A. Helms,et al.  Altered fracture repair in the absence of MMP9 , 2003, Development.

[41]  A. Simpson,et al.  Vascularity in a new model of atrophic nonunion. , 2003, The Journal of bone and joint surgery. British volume.

[42]  A. U. Daniels,et al.  Effect of Fibular Plate Fixation on Rotational Stability of Simulated Distal Tibial Fractures Treated with Intramedullary Nailing , 2003, The Journal of bone and joint surgery. American volume.

[43]  A. Simpson,et al.  Human atrophic fracture non‐unions are not avascular , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[44]  A. Simpson,et al.  The vascularity of atrophic non-unions. , 2002, Injury.

[45]  M. Schaffler,et al.  Prevention of fracture healing in rats by an inhibitor of angiogenesis. , 2001, Bone.

[46]  A. Simpson,et al.  Growth factor expression during the development of atrophic non-union. , 2001, Injury.

[47]  L. Hofbauer,et al.  Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology , 2001, Journal of Molecular Medicine.

[48]  H. Ihn,et al.  Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype , 1998 .

[49]  H. Ihn,et al.  Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. , 1998, The Journal of investigative dermatology.

[50]  M. Feldmann,et al.  Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. , 1992, Arthritis and rheumatism.

[51]  M. Feldmann,et al.  Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[52]  D. Paley,et al.  Ilizarov treatment of tibial nonunions with bone loss. , 1989, Clinical orthopaedics and related research.

[53]  B. Weber,et al.  The treatment of nonunions without electrical stimulation. , 1981, Clinical orthopaedics and related research.